FEC
5-Fluorouracil, Epirubicin, Cyclophosphamide · Adjuvant Breast Cancer Regimen
Indications & Uses
Adjuvant and neoadjuvant therapy for node-positive and high-risk early Breast Cancer.
Contraindications
Severe myocardial impairment, prior cumulative anthracycline maximum dose.
Side Effects & Warnings
Cardiotoxicity, alopecia, nausea, amenorrhea, myelosuppression.
Drug & Dietary Interactions
Extensive interactions; consult specific multi-agent administration and hydration protocols.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.
